Who Owns Anixa Biosciences Stock?
NASDAQ: ANIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 13.85%
- Held by insiders
- 5.62%
- Institutional holders
- 69
- Institutions 13.9%
- Insiders 5.6%
- Public and other 80.5%
Who owns Anixa Biosciences stock?
Institutional investors own about 13.9% of Anixa Biosciences's shares, spread across 69 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 5.62% of ANIX.
The largest institutional holders are Vanguard Capital Management LLC (3.83%), UBS Group AG (1.68%) and Laird Norton Wetherby Trust Company, LLC (1.66%). Together, the top 10 institutions control 12.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ANIX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANIX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.33M | 3.83% | +1.1% |
| UBS Group AG | 585.43K | 1.68% | +6.1% |
| Laird Norton Wetherby Trust Company, LLC | 578.73K | 1.66% | +2.2% |
| D.A. Davidson & Co. | 539.27K | 1.55% | 0.0% |
| Geode Capital Management, LLC | 359.19K | 1.03% | -1.5% |
| Marshall Wace LLP | 328.33K | 0.94% | +89.6% |
| Blackrock Inc. | 199.75K | 0.57% | +17.4% |
| Vanguard Fiduciary Trust Co | 192.36K | 0.55% | +0.7% |
| State Street Corporation | 159.04K | 0.46% | 0.0% |
| GSA Capital Partners LLP | 117.47K | 0.34% | +18.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANIX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 936.93K | 2.70% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 353.88K | 1.02% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 163.41K | 0.47% |
| iShares Trust-iShares Micro-Cap ETF | 106.79K | 0.31% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 52.65K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 46.65K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 24.10K | 0.07% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 21.08K | 0.06% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 17.97K | 0.05% |
| SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund | 12.79K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Anixa Biosciences?
Vanguard Capital Management LLC is the largest institutional shareholder of ANIX, owning 3.83% of shares outstanding (1.33M shares) as of its latest 13F filing.
What percentage of Anixa Biosciences is owned by institutions?
Institutions own about 13.9% of ANIX shares and 14.7% of the public float.
How much of Anixa Biosciences do insiders own?
Insiders, such as officers and directors, own about 5.62% of ANIX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.